The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: a cross-sectional survey

The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: a cross-sectional survey

BackgroundFor patients with interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) with a progressive pulmonary fibrosis (PPF) phenotype, current knowledge of patient experience and symptom burden is limited. This study aimed to describe the patient journey for patients wit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuko Kaneko, Yuko Waseda, Hidekata Yasuoka, Masateru Okazaki, Shoko Nagata, Ryoko Iwasaki, Mark Small, Haruyuki Ishii
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Medicine
Subjects:	idiopathic pulmonary fibrosis progressive pulmonary fibrosis interstitial lung disease antifibrotics treatment real-world data
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1526530/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interstitial lung diseases: a view on the problem
by: O. G. Sych, et al.
Published: (2025-06-01)

Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis
by: Nesrin Ocal, et al.

A clinical case of idiopathic pulmonary fibrosis against the background of comorbid pathology
by: A. V. Teteneva, et al.
Published: (2021-10-01)

Breaking new ground in pulmonary fibrosis: Targeting Pathways and Therapeutic Innovations
by: Swadip Mishra
Published: (2025-04-01)

Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents
by: Vito D’Agnano, et al.
Published: (2024-10-01)

Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review
by: Ignacio Español Montero, et al.
Published: (2025-06-01)

Differential proteomics of interstitial fluid in lung tissue associated with the progression of pulmonary fibrosis in mice
by: Xi Lu, et al.
Published: (2025-04-01)

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland
by: Sebastian Majewski, et al.
Published: (2025-06-01)

Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study
by: Camilla S. Graham, et al.
Published: (2025-05-01)

IDIOPATHIC PULMONARY FIBROSIS. CORRECTION OF ERRORS
by: A. L. Yudin, et al.
Published: (2018-12-01)

The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
by: Stefano Kette, et al.
Published: (2025-03-01)

“POSSIBLE” OR “PROBABLE”. THE NEW APPROACH IN IDIOPATHIC PULMONARY FIBROSIS DIAGNOSIS
by: D. V. Petrov, et al.
Published: (2018-08-01)

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study
by: A. Denis, et al.
Published: (2025-05-01)

What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review
by: Maria Conti, et al.
Published: (2025-07-01)

Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01)

Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis
by: Negar Golchin, et al.
Published: (2025-08-01)

Frequency of imaging phenotypes of pulmonary interstitial fibrosis
by: Wallace T. Miller Jr, et al.
Published: (2025-05-01)

Demographic and Clinical Factors Associated With Diagnostic Confidence in Interstitial Lung DiseaseTake-home Points
by: Mary Beth Scholand, MD, et al.
Published: (2024-12-01)

Impact of Air Pollution on the Long-Term Decline of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease
by: Pablo Mariscal-Aguilar, et al.
Published: (2024-11-01)

Prediction of Pulmonary Hypertension in Patients with Diffuse Parenchymal Lung Disease using Forced Vital Capacity/ Diffusion Capacity of Lung using Carbon Monoxide Ratio: A Cross-sectional Study
by: Anubhab Moulik, et al.
Published: (2025-03-01)

Composition and modification of the lung microbiome in patients with idiopathic pulmonary fibrosis
by: Victoria Maria Ruta, et al.
Published: (2020-10-01)

The role of lung cancer in mortality rate in chronic fibrosing idiopathic interstitial pneumonia
by: Beatriz Morales Chacón, et al.
Published: (2025-05-01)

Ambulatory Oxygen for Pulmonary Fibrosis (OxyPuF): a randomised controlled trial and acceptability study
by: Rachel L Adams, et al.
Published: (2025-07-01)

Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life Study
by: Olcay Aycicek, et al.
Published: (2025-02-01)

Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases
by: Erika M. Novoa-Bolivar, et al.
Published: (2024-10-01)

Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review
by: Domenico Sambataro, et al.
Published: (2025-03-01)

Clinical-Epidemiological Profile and Distribution of Interstitial Lung Diseases: A Tertiary Care Centre Experience from North India
by: Anubhuti Singh, et al.
Published: (2024-09-01)

Association of tracheal diameter with respiratory function and fibrosis severity in idiopathic pulmonary fibrosis patients
by: Nevin Fazlıoğlu, et al.
Published: (2025-04-01)

Machine learning identifies lipid-associated genes and constructs diagnostic and prognostic models for idiopathic pulmonary fibrosis
by: Xingren Liu, et al.
Published: (2025-07-01)

Peripheral and pulmonary telomere lengths in patients with non-idiopathic pulmonary fibrosis interstitial lung diseases
by: Yujie Shi, et al.
Published: (2025-08-01)

Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases
by: A. A. Speranskaya, et al.
Published: (2016-03-01)

Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease
by: Aparna C Swaminathan, et al.
Published: (2024-10-01)

Idiopathic Pulmonary Fibrosis and Hypersensitive Pneumonitis: A Fresh View on The Role of Genetic and Epigenetic Factors in The Development and Course of Diseases
by: E. E. Arkhangelskaya, et al.
Published: (2024-11-01)

Person-centred health outcomes in the routine care for people with progressive pulmonary fibrosis: the COCOS-IPF project’s European survey on healthcare professionals’ views and practices
by: Vivien Somogyi, et al.
Published: (2025-02-01)

A bibliometric analysis of research on idiopathic pulmonary fibrosis
by: ZENG Wei, et al.
Published: (2025-05-01)

Clinical implications of idiopathic pulmonary fibrosis and lung cancer
by: Hongseok Yoo, et al.
Published: (2025-03-01)

Editorial: Reviews in: pulmonary medicine 2023
by: Roberto G. Carbone, et al.
Published: (2025-03-01)

Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis
by: Brittany Duchene
Published: (2024-01-01)

Lung transplantation for connective tissue disease–related interstitial lung disease: Clinical outcomes compared to idiopathic pulmonary fibrosis
by: Sarah L. Khan, MD, MHS, et al.
Published: (2025-08-01)

The Impact of Corticosteroids on Mortality in Acute Exacerbations of Idiopathic Pulmonary Fibrosis: A Meta-Analysis
by: Pier-Valerio Mari, et al.
Published: (2025-03-01)